Hester Biosciences Limited (BOM:524669)

Hester Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	14,795	10,667	11,818	12,934	23,099	16,306
Market Cap Growth	-4.00%	-9.74%	-8.63%	-44.00%	41.66%	107.20%
Enterprise Value	16,983	13,063	14,503	15,490	24,167	17,452
Last Close Price	1739.15	1249.57	1381.11	1504.56	2675.03	1880.37
PE Ratio	36.36	38.81	62.57	48.58	58.75	47.36
PS Ratio	4.69	3.41	3.80	4.65	9.37	7.49
PB Ratio	4.21	3.27	3.90	4.48	8.64	6.91
P/TBV Ratio	4.48	3.47	4.11	4.67	8.96	7.17
P/FCF Ratio	-	24.29	49.69	-	-	94.19
P/OCF Ratio	-	16.54	24.53	54.82	265.14	28.09
EV/Sales Ratio	5.38	4.18	4.66	5.57	9.80	8.02
EV/EBITDA Ratio	21.82	21.06	24.17	24.81	33.90	24.23
EV/EBIT Ratio	27.59	28.63	33.63	36.86	43.91	29.52
EV/FCF Ratio	-	29.74	60.97	-	-	100.81
Debt / Equity Ratio	0.61	0.69	0.85	0.95	0.85	0.47
Debt / EBITDA Ratio	2.97	3.59	4.28	4.38	3.19	1.52
Debt / FCF Ratio	-	5.09	10.84	-	-	6.36
Net Debt / Equity Ratio	0.59	0.66	0.80	0.90	0.76	0.38
Net Debt / EBITDA Ratio	2.86	3.49	4.04	4.16	2.85	1.23
Net Debt / FCF Ratio	-	4.93	10.19	-4.79	-2.33	5.13
Asset Turnover	-	0.48	0.47	0.45	0.51	0.55
Inventory Turnover	-	1.27	1.24	1.03	0.99	0.84
Quick Ratio	-	0.70	0.95	0.68	0.85	1.15
Current Ratio	-	1.56	2.04	1.53	2.01	2.63
Return on Equity (ROE)	-	9.16%	7.16%	10.09%	15.69%	15.68%
Return on Assets (ROA)	-	4.33%	4.05%	4.26%	7.07%	9.26%
Return on Invested Capital (ROIC)	7.80%	6.11%	5.23%	5.76%	10.22%	12.93%
Return on Capital Employed (ROCE)	-	8.60%	7.70%	8.10%	11.80%	16.90%
Earnings Yield	2.77%	2.58%	1.60%	2.06%	1.70%	2.11%
FCF Yield	-	4.12%	2.01%	-4.19%	-3.77%	1.06%
Dividend Yield	0.40%	0.56%	0.43%	0.53%	0.37%	0.53%
Payout Ratio	-	18.80%	36.28%	31.95%	21.63%	16.31%
Total Shareholder Return	1.01%	0.56%	0.43%	0.53%	0.37%	0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.